AA has done commercially sponsored research for Novo Nordisk, is an advisory board member for Novo Nordisk, 7TM, Neuro-Search, Amylin/Takeda, Pathway Genomics, Jenny Craig, and has been a consultant to the following companies within the last 3 years: Orexigen, Vivus, Arena, GSK, Novo Nordisk, 7TM, Pharma, Neurosearch, and Johnson and Johnson
Our providers work with members to educate them on safe approaches to weight loss and the potential risks of compounded GLP-1s
Oxytocin-loaded hydrogel promotes cartilage regeneration and regulates microenvironment
As pramlintide affects the rate at which food passes from stomach to the small intestines, or gastric emptying, pramlintide should not be prescribed for patients consuming medications that alter gastrointestinal motility (e.g., atropine) or medications that reduce the intestinal absorption of nutrients The following drugs may increase the risk of hypoglycemia when administered with pramlintide: Pramlintide and these drugs should be co-administered with utmost care
Meal timing and size matter significantly
/assets/images/provider/photos/2789813.jpeg)
